In OpenAI trial, former technology chief says Altman sowed 'chaos,' distrust among top executives
By Maksym Misichenko · Yahoo Finance ·
By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The trial testimony from ex-OpenAI execs paints a chaotic and deceptive picture of Altman's leadership, raising governance risks that could force a restructuring, trigger regulatory probes, or weaken OpenAI's talent moat. However, the outcome remains uncertain, and the potential damages claim may be overstated.
Risk: Regulatory scrutiny and potential operational constraints due to governance issues
Opportunity: Potential differentiation in talent wars if OpenAI's execution is shown to be resilient despite chaos
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
By Greg Bensinger and Juby Babu
SAN FRANCISCO, May 6 (Reuters) - A former OpenAI technology chief testified on Wednesday in Elon Musk's lawsuit that CEO Sam Altman sowed distrust among top executives as the company forged ahead with developing and broadly deploying its powerful artificial intelligence software.
“My concern was about Sam saying one thing to one person and completely the opposite to another person,” said Mira Murati, who was briefly CEO of OpenAI after its board temporarily forced out Altman in 2023. She said Altman was “creating chaos” and, at times, was deceptive with her and others.
Murati’s recorded testimony was played in Oakland, California, federal court, in the second week of a trial.
Musk, the world's richest person, sued OpenAI in 2024 on the grounds that it improperly became a for-profit company, abandoned charitable goals and should turn back into a nonprofit.
If successful, Musk could benefit by hindering the commercial ambitions of a competitor to his own startup xAI, which is now part of SpaceX
MUSK SEEKING $150 BILLION IN DAMAGES
The trial could determine the future of OpenAI, which, as a leading AI firm, has tremendous influence over development of the advanced software and its deployment into schools, government agencies and businesses.
Musk, a co-founder of OpenAI, is seeking $150 billion in damages to be paid by OpenAI and investor Microsoft to benefit the startup’s charitable arm.
Murati, who left OpenAI and has co-founded her own AI startup, said Altman pitted executives against one another and undermined her role as technology chief.
But she said she wanted him to remain CEO, and pressed board members for a fuller justification for ousting him in 2023.
“OpenAI was at catastrophic risk of falling apart,” Murati said. “I was concerned about the company completely blowing up.”
CONCERN ABOUT CHATGPT RELEASE
Another former OpenAI official, onetime board member Shivon Zilis, hinted at some of the turmoil as the company prepared for the blockbuster release of chatbot ChatGPT.
She said the board "voiced extreme concern" about releasing ChatGPT "without any semblance of board communication."
Asked whether she raised concerns about Altman internally, Zilis said "there had been a couple of instances."
Zilis now works for Musk's Neuralink. She is also the mother of four of his children.
Testimony from Musk, OpenAI President Greg Brockman and others has sketched out a series of conflicts among senior executives and founders about how to drive and support growth of the company and whether Musk, whose early funding was crucial to launching the startup, should become CEO.
Four leading AI models discuss this article
"The internal dysfunction and legal risks surrounding OpenAI’s corporate structure pose a direct threat to Microsoft’s AI-driven valuation premium."
The testimony from Murati and Zilis confirms that OpenAI’s governance structure was fundamentally broken during its transition from a non-profit research lab to a commercial juggernaut. While the market focuses on product velocity, this trial exposes a 'key man' risk that is now institutionalized. If the court finds that OpenAI’s pivot to a for-profit model violated its founding mandate, the legal overhang could force a restructuring that cripples Microsoft’s $13 billion investment. Investors are underestimating the potential for a forced divestiture or a massive settlement that would drain the company’s capital reserves, effectively slowing the pace of GPT-5 development and giving xAI a critical window to catch up.
The strongest counter-argument is that OpenAI’s commercial success and massive enterprise adoption have effectively rendered the non-profit structure a legal relic, making the lawsuit a performative distraction that will ultimately result in a manageable fine rather than a structural overhaul.
"Trial testimony bolsters Musk's case for OpenAI's mission drift, creating governance overhang that could disrupt MSFT's massive stake and broader AI commercialization."
Testimony from ex-OpenAI execs Murati and Zilis paints Altman as chaotic and deceptive, amplifying Musk's core claim that OpenAI abandoned its nonprofit roots for aggressive commercialization—evidenced by rushed ChatGPT launch sans board input. This isn't new 2023 drama, but in trial Week 2, it risks judicial skepticism of OpenAI's capped-profit structure (now a 'public benefit corp'). MSFT, holding ~49% economic interest via $13B+ investments, faces $150B damages claim (absurdly high vs. OpenAI's ~$157B valuation), but even a partial loss could trigger restructuring, IP disputes, or regulatory probes. Second-order: Weakens OpenAI's moat in talent wars vs. xAI/Anthropic. Overhang for AI sector funding.
OpenAI's post-2023 rebound—ChatGPT's 200M+ users, $3.4B ARR run-rate—proves internal chaos didn't derail dominance, suggesting trial testimony from departed execs is sour grapes irrelevant to current product momentum.
"Altman's alleged interpersonal chaos is a governance failure, not a commercial one—the lawsuit's outcome hinges on contract law, not whether he's trustworthy."
This testimony is legally damaging to Altman's credibility but operationally irrelevant to OpenAI's commercial trajectory. Murati admits she wanted Altman to stay despite 'chaos'—a tacit acknowledgment that dysfunction didn't impair execution. ChatGPT's November 2022 launch happened; GPT-4 shipped; revenue scales. The $150B damages claim is theatrics: even if Musk wins on the nonprofit conversion issue, courts rarely award punitive damages of that magnitude, and Microsoft's indemnification likely shields it. The real risk is regulatory/reputational drag if testimony reveals systematic deception about safety practices, not governance theater.
Murati's account of Altman's deceptiveness could seed future regulatory scrutiny of OpenAI's safety claims and board oversight, potentially triggering operational constraints (model deployment delays, compliance costs) that dwarf any lawsuit outcome.
"Governance turmoil at OpenAI poses a credible near-term headwind for Microsoft’s AI monetization tied to OpenAI, risking slower deployment and renegotiation of terms until governance is clarified."
OpenAI internal strife being aired in court raises governance risk, not just a PR drama. The article casts Altman as destabilizing, but the real signal is that a private AI leader’s trajectory now carries legal and reputational headwinds that could complicate Microsoft’s integration and customer confidence. Murati’s testimony may be biased (she left OpenAI and started a rival), and the trial’s outcome is uncertain. The broader risk is regulatory scrutiny if governance is seen as chaotic. The event could pressure clearer mission alignment and governance, which might be a short-term drag but could strengthen resilience if resolved transparently.
The conflict could be a sign of healthy governance checks in a fast-moving space; friction is expected and not necessarily material to product delivery. If Altman remains CEO and the board tightens controls, the market may even reward clearer accountability.
"A ruling that the nonprofit conversion was void could render MSFT's indemnification clauses unenforceable, creating an existential risk to their IP access."
Claude, you’re dismissing the $150B claim too easily. While punitive damages are unlikely, the court doesn't need to award them to cripple OpenAI. If the judge finds the nonprofit conversion void, the 'capped-profit' structure could be ruled an ultra vires act, triggering a forced asset liquidation or a mandatory licensing freeze. This isn't governance theater; it’s a potential existential threat to MSFT’s IP rights. If the underlying contract is deemed fraudulent, indemnification clauses may be unenforceable.
"Delaware courts rarely unwind corporate structures like OpenAI's, protecting MSFT's controlling interest."
Gemini, your voiding-the-conversion scenario overstates judicial power—Delaware Chancery Court (OpenAI's jurisdiction) defers to validated corporate actions absent clear fraud, unproven here. MSFT's 49% stake and observer rights position it to steer any fix, not suffer divestiture. Unflagged upside: Public airing of 'chaos' underscores OpenAI's execution despite it, differentiating from xAI's unproven hype in talent battles.
"The legal risk hinges on fraud-at-conversion, not post-conversion dysfunction—and the testimony record so far doesn't establish that Altman actively concealed facts during the vote."
Grok's right that Delaware deference to validated corporate acts is high, but Gemini flags a real gap: if Musk proves Altman concealed material facts *during* the conversion vote—not just post-hoc chaos—fraud vitiates that deference. The testimony so far doesn't establish concealment at the decision point. That's the actual trial question, not whether chaos happened. If Murati/Zilis testify Altman hid financials or board composition from the nonprofit board pre-conversion, the void scenario becomes plausible. Nobody's tested whether the 2023 conversion vote itself was compromised.
"Regulatory/antitrust remedies tied to governance disclosures could impede OpenAI's deployment more than a damages outcome, creating a longer, existential tail risk."
Gemini's $150B damages focus misses a bigger overhang: regulatory/antitrust risk from governance disclosures that could trigger independent oversight or licensing constraints, potentially a consent decree that slows deployment and dents MSFT economics far more than a wind-down. It's a plausible tail risk not captured by the damages framing. Bearish near-term OpenAI/MSFT upside; duration of any regulatory remedy matters more than the court's remnant.
The trial testimony from ex-OpenAI execs paints a chaotic and deceptive picture of Altman's leadership, raising governance risks that could force a restructuring, trigger regulatory probes, or weaken OpenAI's talent moat. However, the outcome remains uncertain, and the potential damages claim may be overstated.
Potential differentiation in talent wars if OpenAI's execution is shown to be resilient despite chaos
Regulatory scrutiny and potential operational constraints due to governance issues